"Hepatitis D" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Descriptor ID |
D003699
|
MeSH Number(s) |
C02.440.450 C02.782.450 C06.552.380.705.450
|
Concept/Terms |
Hepatitis D- Hepatitis D
- Infection, Delta
- Hepatitis, Delta
- Delta Hepatitis
- Hepatitides, Delta
- Delta Infection
- Infections, Delta
Superinfection, Delta- Superinfection, Delta
- Delta Superinfections
- Superinfections, Delta
- Delta Superinfection
Amazon Black Fever- Amazon Black Fever
- Fever, Amazon Black
- Labrea Disease
- Disease, Labrea
- Diseases, Labrea
- Labrea Diseases
- Black Fever, Amazon
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis D".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis D".
This graph shows the total number of publications written about "Hepatitis D" by people in this website by year, and whether "Hepatitis D" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2017 | 8 | 1 | 9 |
2018 | 12 | 2 | 14 |
2019 | 6 | 0 | 6 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis D" by people in Profiles.
-
AMSSM Position Statement Update: Blood-Borne Pathogens in the Context of Sports Participation. Clin J Sport Med. 2020 07; 30(4):283-290.
-
Hepatitis Delta Estimates in the United States Revisited. Clin Infect Dis. 2019 10 30; 69(10):1833-1834.
-
Reply to Soriano, Gómez-Gallego, and Corral. Clin Infect Dis. 2019 10 30; 69(10):1834-1835.
-
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients. J Hepatol. 2019 10; 71(4):834-839.
-
Case 15-2019: A 55-Year-Old Man with Jaundice. N Engl J Med. 2019 May 16; 380(20):1955-1963.
-
Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status. J Infect Dis. 2019 01 29; 219(4):568-577.
-
NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases. Int J Infect Dis. 2019 Mar; 80:147-152.
-
The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort. Dig Liver Dis. 2019 03; 51(3):438-442.
-
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut. 2019 03; 68(3):512-521.
-
Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain. Eur J Gastroenterol Hepatol. 2018 09; 30(9):1060-1062.